Cargando…

Priapism secondary to tamsulosin: A case report

BACKGROUND: Tamsulosin is the most potent adrenergic alpha-1 antagonist used for treatment of benign prostatic hyperplasia (BPH). Priapism has been reported as a rare side effect through direct inhibition of the sympathetic input necessary for detumesence. PRESENTATION OF CASE: We describe an otherw...

Descripción completa

Detalles Bibliográficos
Autores principales: Prihadi, Johannes Cansius, Kusumajaya, Christopher
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7322206/
https://www.ncbi.nlm.nih.gov/pubmed/32698265
http://dx.doi.org/10.1016/j.ijscr.2020.06.022
_version_ 1783551599446065152
author Prihadi, Johannes Cansius
Kusumajaya, Christopher
author_facet Prihadi, Johannes Cansius
Kusumajaya, Christopher
author_sort Prihadi, Johannes Cansius
collection PubMed
description BACKGROUND: Tamsulosin is the most potent adrenergic alpha-1 antagonist used for treatment of benign prostatic hyperplasia (BPH). Priapism has been reported as a rare side effect through direct inhibition of the sympathetic input necessary for detumesence. PRESENTATION OF CASE: We describe an otherwise healthy man with recurrent and then persistent unresolved priapism after the use of tamsulosin and concomitant use of ace inhibitor and beta blocker for hypertension. We then performed aspiration and intracavernosal irrigation of saline and vasoconstrictive agent. DISCUSSION: Health-care professionals should inform all patients taking such medications about this rare but possible serious adverse effect. Tamsulosin is a useful medication for the management of Lower Urinary Tract Symptoms (LUTS) related to BPH and medical expulsion of distal ureteric calculi. However, its use may be associated on rare occasions with priapism, hence Health-care professionals should be aware in order to advice all patients taking such medications about this rare but serious adverse effect and to seek help as soon as possible. CONCLUSION: With caution against the use of tamsulosin in hypertension treated patient, the possibility of the adverse effect can be more noticed and encourage practitioners to look for other alternatives that are safer and better for dealing with LUTS in the future and develop better treatment strategies.
format Online
Article
Text
id pubmed-7322206
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-73222062020-06-30 Priapism secondary to tamsulosin: A case report Prihadi, Johannes Cansius Kusumajaya, Christopher Int J Surg Case Rep Article BACKGROUND: Tamsulosin is the most potent adrenergic alpha-1 antagonist used for treatment of benign prostatic hyperplasia (BPH). Priapism has been reported as a rare side effect through direct inhibition of the sympathetic input necessary for detumesence. PRESENTATION OF CASE: We describe an otherwise healthy man with recurrent and then persistent unresolved priapism after the use of tamsulosin and concomitant use of ace inhibitor and beta blocker for hypertension. We then performed aspiration and intracavernosal irrigation of saline and vasoconstrictive agent. DISCUSSION: Health-care professionals should inform all patients taking such medications about this rare but possible serious adverse effect. Tamsulosin is a useful medication for the management of Lower Urinary Tract Symptoms (LUTS) related to BPH and medical expulsion of distal ureteric calculi. However, its use may be associated on rare occasions with priapism, hence Health-care professionals should be aware in order to advice all patients taking such medications about this rare but serious adverse effect and to seek help as soon as possible. CONCLUSION: With caution against the use of tamsulosin in hypertension treated patient, the possibility of the adverse effect can be more noticed and encourage practitioners to look for other alternatives that are safer and better for dealing with LUTS in the future and develop better treatment strategies. Elsevier 2020-06-12 /pmc/articles/PMC7322206/ /pubmed/32698265 http://dx.doi.org/10.1016/j.ijscr.2020.06.022 Text en © 2020 IJS Publishing Group Ltd. Published by Elsevier Ltd. http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Prihadi, Johannes Cansius
Kusumajaya, Christopher
Priapism secondary to tamsulosin: A case report
title Priapism secondary to tamsulosin: A case report
title_full Priapism secondary to tamsulosin: A case report
title_fullStr Priapism secondary to tamsulosin: A case report
title_full_unstemmed Priapism secondary to tamsulosin: A case report
title_short Priapism secondary to tamsulosin: A case report
title_sort priapism secondary to tamsulosin: a case report
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7322206/
https://www.ncbi.nlm.nih.gov/pubmed/32698265
http://dx.doi.org/10.1016/j.ijscr.2020.06.022
work_keys_str_mv AT prihadijohannescansius priapismsecondarytotamsulosinacasereport
AT kusumajayachristopher priapismsecondarytotamsulosinacasereport